02:04 PM EDT, 09/05/2025 (MT Newswires) -- An upcoming Health and Human Services report is expected to suggest that the use of Kenvue's ( KVUE ) Tylenol by pregnant women may be linked to autism, The Wall Street Journal reported Friday, citing people familiar with the matter.

The report, anticipated to be published this month, is also expected to suggest that a medicine derived from folate may help treat symptoms of the developmental disorder in some individuals, according to the news outlet.

Kenvue ( KVUE ), whose shares were down 10.1% at 1:55 p.m. ET, did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 18.47, Change: -2.08, Percent Change: -10.10